Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Full description

Bibliographic Details
Main Authors: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2004-12-01
Series:Российский кардиологический журнал
Subjects:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2326

Similar Items

Similar Items